Nonclinical Evaluation of the Immunotoxic Potential of Pharmaceuticals
Docket Number: FDA-2019-D-5607 Issued by: Guidance Issuing Office Center for Drug Evaluation and Research The purpose of this guidance is to assist sponsors in the nonclinical evaluation of the immunotoxic potential of pharmaceuticals. Immunotoxicity is, …